FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis

• Published in: American journal of hematology 2014-10, Vol.89 (10), p.954-963
• Main Authors: Zhang, Xin, Campreciós, Genís, Rimmelé, Pauline, Liang, Raymond, Yalcin, Safak, Mungamuri, Sathish Kumar, Barminko, Jeffrey, D'Escamard, Valentina, Baron, Margaret H., Brugnara, Carlo, Papatsenko, Dmitri, Rivella, Stefano, Ghaffari, Saghi
• Format: Article
• Language: English
• Subjects: Animals; beta-Thalassemia - genetics; beta-Thalassemia - metabolism; beta-Thalassemia - pathology; Disease Models, Animal; Erythroblasts - metabolism; Erythroblasts - pathology; Erythropoiesis; Forkhead Box Protein O3; Forkhead Transcription Factors - genetics; Forkhead Transcription Factors - metabolism; Hematology; Homeostasis; Mice; Mice, Knockout; Signal Transduction; TOR Serine-Threonine Kinases - genetics; TOR Serine-Threonine Kinases - metabolism
• ISSN: 0361-8609; 1096-8652
• DOI: 10.1002/ajh.23786

Ineffective erythropoiesis is observed in many erythroid disorders including β‐thalassemia and anemia of chronic disease in which increased production of erythroblasts that fail to mature exacerbate the underlying anemias. As loss of the transcription factor FOXO3 results in erythroblast abnormalities similar to the ones observed in ineffective erythropoiesis, we investigated the underlying mechanisms of the defective Foxo3−/− erythroblast cell cycle and maturation. Here we show that loss of Foxo3 results in overactivation of the JAK2/AKT/mTOR signaling pathway in primary bone marrow erythroblasts partly mediated by redox modulation. We further show that hyperactivation of mTOR signaling interferes with cell cycle progression in Foxo3 mutant erythroblasts. Importantly, inhibition of mTOR signaling, in vivo or in vitro enhances significantly Foxo3 mutant erythroid cell maturation. Similarly, in vivo inhibition of mTOR remarkably improves erythroid cell maturation and anemia in a model of β‐thalassemia. Finally we show that FOXO3 and mTOR are likely part of a larger metabolic network in erythroblasts as together they control the expression of an array of metabolic genes some of which are implicated in erythroid disorders. These combined findings indicate that a metabolism‐mediated regulatory network centered by FOXO3 and mTOR control the balanced production and maturation of erythroid cells. They also highlight physiological interactions between these proteins in regulating erythroblast energy. Our results indicate that alteration in the function of this network might be implicated in the pathogenesis of ineffective erythropoiesis. Am. J. Hematol. 89:954–963, 2014. © 2014 Wiley Periodicals, Inc.